Drug Profile
Research programme: antifungals - Pfizer
Alternative Names: Antifungals research programme - Pharmacia; VIC-107536Latest Information Update: 14 Jan 2010
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 25 Jan 2005 Preclinical trials in Mycoses in USA (unspecified route)
- 18 Aug 2000 Preclinical development for Mycoses in USA (Unknown route)